Atomwise, OncoStatyx launch JV to target triple-negative breast cancer; Cancer biotech woos former Spark COO John Furey
→ Celyad is teaming up with Be The Match BioTherapies, a cell and gene therapy solutions provider, on a clinical trial of its non …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
